Trending Topic

11 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Lung cancer is the second most common type of cancer worldwide and in the USA, with its incidence varying depending on geographic and socioeconomic factors.1–3 According to data from the Global Cancer Observatory: Cancer Incidence, Mortality and Prevalence (GLOBACAN) database, an estimated 2.48 million new cases of lung cancer were reported in 2022.4,5 Although lung cancer rates in the […]

Timothy A Yap, AACR 2018 – Advances in Precision Cancer Medicine

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: May 1st 2018

Timothy A Yap, from the University of Texas MD Anderson Cancer Center, Houston, TX, US, discusses recent advances and challenges in precision cancer medicine, and how we can improve awareness and understanding of this important subject in the wider community.

1. What have been the most important advances in precision cancer medicine in the last year? (0:08)
2. What are the short- and long-term goals of precision medicine in oncology? (1:55)
3. How can we overcome the challenges of tumour heterogeneity and clonal evolution? (2:36)
4. How do you decide which trial to offer patients using precision medicine technologies? (3:46)
5. How can we improve public awareness and understanding of precision medicine? (4:41)

Speaker disclosures: Timothy A Yap has nothing to disclose in relation to this video interview.

Filmed at the American Association for Cancer Research (AACR) Annual Meeting 2018, Chicago, IL, US, April 14–18, 2018.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup